Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05375903
Title A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors UroGen Pharma Ltd.
Age Groups: senior | adult
Covered Countries USA | ITA | ESP

No variant requirements are available.